Express summary - Wrap Up
Big | Enterprise | Movement | Towards
Big Player
DSM and Firmieyi merge to layout alternative protein field
0Quille Seed Industry plans to sprint Beijing Stock Exchange A shares listed
LanzaTech Join forces with Danone to break through carbon capture one-step production of monoethylene glycol technology
Zymergen Joint Octant to develop drugs for treating diseases
Muen Bio and Inmena to create the world's largest microbial gene component library
Huafeng Group acquires the bio-based business of DuPont, the United States,
3｜Enterprise｜Operation｜Towards
DSM and Firmeni merge to layout the alternative protein field
2022 On May 31, DSM and Firmeni announced that they had reached a business merger agreement to establish a leading creative and innovative partner in nutrition, beauty and health with . The combined company's extensive global layout will provide customers with an unprecedented R&D, production and sales network. Currently, DSM and Firmeni and Italy have both layouts in the field of alternative protein . I believe that after the merger, it will definitely bring new innovations in the field of alternative protein.
Qiule Seed Industry plans to sprint for the Beijing Stock Exchange A-share listing
On May 30, 2022, Henan Qiule Seed Technology Co., Ltd. announced that has once again sprinted for the A-share listing . The funds raised by this A-share IPO are used for the biological breeding R&D capacity improvement project and the supplementary working capital project , and the amount of funds raised is .265 billion . Previously, Qiule Seed Industry applied for listing on science and technology innovation board in June 2020, and withdrew its listing application in October of that year. Qiule Seed Industry is mainly engaged in the research and development, breeding, processing, promotion, sales and technical services of crop seeds such as corn, peanuts, and wheat. The company has a complete "integrated breeding, breeding and promotion" industrial system, and is one of the first 32 "integrated breeding, breeding and promotion" enterprises in , and is , a national high-tech enterprise in .
LanzaTech joins forces with Danone to break through the carbon capture one-step method for producing monoethylene glycol
On May 26, 2022, LanzaTech, a synthetic biotechnology carbon capture company to be listed, cooperated with Danone to achieve a technological breakthrough in the " carbon capture one-step method for producing monoethylene glycol ": it was successfully transformed and obtained a engineering bacteria, which can directly fix carbon from gas and use it as a carbon source to produce monoethylene glycol (MEG). Next step LanzaTech will continue to amplify its one-step carbon capture production monoethylene glycol technology with the support of Danone and expand its production scale.
Zymergen and Octant develop drugs for treating diseases
Recently, biotechnology company Zymergen announced an agreement with Octant, the development of innovative drugs. Zymergen will sell its modular automation system to expand Octant's next-generation platform for developing breakthrough drugs. In this collaboration, Zymergen will integrate it into Octant's existing platform using its complete automation solution, , including , including modular hardware, modern web-based software, custom and turnkey workflows, and proactive monitoring and support, which uses synthetic biology , high-throughput multiple analysis, synthetic chemistry and computing to design and ask about drugs, protein and signaling pathways .
Muen Bio and Inmena create the world's largest microbial gene element library
Recently, Muen (Guangzhou) Biotechnology Co., Ltd., a leading domestic microbiome discovery and industrialization platform, announced a cooperation with Inmena, a global leader in gene sequencing technology. The company will use Inmena's new generation sequencing (NGS) technology to carry out China's largest microbial genome sequencing program , and complete the genome sequencing of 300,000 to 500,000 diverse microorganisms within the next five years, so as to create the world's largest microbial standardized gene element library , and agricultural trait gene library , fully realize the digitization of strain resources, and complete the genome sequencing of 300,000 to 500,000 diverse microorganisms within the next five years. use” strategy.
Huafeng Group acquired DuPont's bio-based business
On June 1, 2022, Huafeng Group acquired the bio-based product-related business and technology, which was divested by DuPont's US. This time, Huafeng Group acquired the assets of its business under DuPont , mainly including its two production bases in the United States. The main business is to develop, produce and sell bio-based PDO, which can produce high-performance polyester plastic and make it have biodegradable properties that are easy to natural circulation and produce , a kind of environmentally friendly fiber material with performance advantages sold under the Sorona® brand. This is the largest overseas merger and acquisition transaction by Huafeng Group so far. Behind this multinational merger and acquisition is the specific implementation of Huafeng Group's "14th Five-Year Plan" strategy to accelerate the internationalization of the industry and product environmental protection strategy.
More original content & information benefits, follow Zhigeng Tech Cube~
